查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830961

質子治療系統市場

Proton Therapy Systems Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

質子治療系統市場預計將從 2024 年的 15.6107 億美元擴大到 2031 年的 32.7484 億美元，2025-2031 年期間的複合年成長率預計為 11.2%。

市場洞察與分析師觀點：質子治療系統市場的預測可以幫助該領域的利害關係人制定成長策略。

質子治療系統是一種先進的醫療設備，用於對腫瘤進行高精度放射治療。這些系統體積龐大，由加速器（迴旋加速器）、束流傳輸系統、能量選擇系統及旋轉機架輻照設備所組成。由於質子治療在治療特定癌症類型方面療效顯著，全球對質子治療的需求日益成長。隨著癌症發生率的上升，對先進治療的需求不斷成長，以及政府對質子治療設施的支持力度不斷加大，這些因素正在推動質子治療系統市場的成長。然而，質子治療系統的高成本和占地面積對市場擴張構成了挑戰。此外，個人化治療方法的日益普及以及技術的進步預計將在未來幾年為質子治療系統市場帶來新的趨勢。

成長動力：癌症發生率上升，對先進治療的需求增加，推動市場成長根據國際癌症研究機構 (IARC) 的數據，2022 年肺癌、乳癌和攝護腺癌的發生率最高，年齡標準化率分別為每 10 萬人口 23.6 例、47.1 例和 29.4 例。 IARC 估計表明，預計癌症病例總數將從 2022 年的 1,998 萬增加到 2030 年的 2,371 萬，到 2045 年將達到 3,097 萬。各種癌症類型，包括頭頸癌（鼻癌、口腔癌、眼癌和喉癌）和腦癌，都有特定的治療需求，導致對調強質子治療 (IMPT) 等先進治療方式的需求增加。傳統放射療法，例如X光放射療法，也會使腫瘤周圍的健康組織暴露於輻射之下，從而產生副作用並可能導致繼發性癌症。相較之下，質子治療能夠有效治療腦部和頭頸部的複雜腫瘤，同時最大限度地減少對鄰近健康組織的傷害。因此，癌症的高發病率和對先進治療方案的需求正在推動質子治療系統市場的成長。

策略性洞察限制：質子治療系統成本高、佔地面積大質子治療系統是一種用於精準放射治療腫瘤的複雜醫療設備。系統體積龐大，包括加速器（迴旋加速器）、束流傳輸系統、能量選擇系統和旋轉機架輻照設備，佔用空間大，設備成本高。據賓州大學 (Oncolink) 稱，質子治療系統中的迴旋加速器重達 200 噸，直徑為 6-12 英尺。機架重約 100 噸，直徑 40 英尺。 2021 年發表在 IOPscience 上的一項研究表明，即使是緊湊型設計（單室設置）也需要 100 平方米的面積，而多室質子治療系統則需要 200-400 平方米的空間。

此外，質子治療系統高度資本密集。例如，單室系統的成本約為3000萬至5000萬美元，而多機架質子治療系統的起價約為3億美元，通常僅安裝在大型醫院和大學系統中。因此，高額的資本投入和所需的龐大安裝空間是阻礙質子治療系統市場成長的重要因素。

報告細分和範圍：透過檢查以下細分來分析質子治療系統市場：設定類型和應用。

根據設置類型，市場分為單室和多室。 2022年，多室部分在質子治療系統市場中佔據了更大的佔有率。此外，預計單室部分在預測期內將呈現更快的複合年成長率。

根據應用，市場分為腦部和中樞神經系統癌症、頭頸癌、攝護腺癌、乳癌、肺癌、胃腸道癌症等。腦部和中樞神經系統癌症領域在2022年佔據了質子治療系統市場的最大佔有率，預計在預測期內將實現最高的複合年成長率。

區域分析：從地理上講，質子治療系統市場報告的範圍涵蓋北美、歐洲、亞太地區、南美和中美以及中東和非洲。 2022 年，北美佔據了最大的市場佔有率。先進醫療設備的日益普及和採用、癌症的高發病率以及主要參與者的產品創新促進了北美質子治療系統市場的成長。根據美國癌症協會的估計，美國在 2023 年記錄了約 195 萬例新發癌症病例和約 61 萬例癌症相關死亡病例，與 2020 年報告的 160 萬例病例和 60 萬例死亡病例相比顯著增加。根據粒子治療合作組織的數據，到 2023 年底，美國的質子治療系統數量位居全球第一，共有 46 套治療設施。

質子治療系統市場報告範圍產業發展與未來機會：正如公司新聞稿所報導的，質子治療系統市場主要參與者的幾項策略發展重點如下：

2024年1月，OncoRay推出了全身磁振造影引導質子治療系統原型，該系統旨在治療期間利用磁振造影 (MRI) 即時追蹤移動的腫瘤。 MRI 增強了腫瘤的可視性，與傳統影像方法相比，其對比度更高，能夠更準確地將腫瘤與周圍健康組織區分開來，並更好地定義照射區域。 2023年12月，養和醫療集團在香港筲箕灣阿公岩的養和東區醫療中心開設了一家新的質子治療中心。該中心擁有先進的質子治療系統和兩間最先進的治療室，包括兩台半旋轉質子治療機架、最新的光束傳輸系統和同步加速器。競爭格局和主要公司：質子治療系統市場報告中介紹的知名公司包括 Varian Medical Systems Inc、住友重工有限公司、日立有限公司、Ion Beam Applications SA、Mevion Medical Systems、Provision Healthcare LLC、ProTom International、Optivus Proton Therapy Inc、Advanced Oncotherapy plc 和 B dot Medical Inc。這些公司專注於開發新技術、增強現有產品並擴大其地理覆蓋範圍以滿足日益成長的全球需求。

目錄

第1章：簡介

第 2 章：執行摘要

  • 關鍵見解
  • 市場吸引力分析

第3章：研究方法

第4章：質子治療系統市場格局

  • 概述
  • PEST分析
  • 生態系分析
    • 價值鏈中的供應商列表

第5章：質子治療系統市場－關鍵市場動態

  • 關鍵市場促進因素
  • 主要市場限制因素
  • 關鍵市場機會
  • 未來趨勢
  • 促進因素和限制因素的影響分析

第6章：質子治療系統市場-全球市場分析

  • 質子治療系統 - 全球市場概覽
  • 質子治療系統－全球市場及2030年預測

第7章：質子治療系統市場-收入分析-依設定類型，2020-2030

  • 概述
  • 單人房
  • 多房間

第 8 章：質子治療系統市場 - 收入分析 - 按應用，2020-2030 年

  • 概述
  • 腦部和中樞神經系統癌症
  • 頭頸癌
  • 攝護腺癌
  • 乳癌
  • 肺癌
  • 胃腸道癌症
  • 其他

第9章：質子治療系統市場-收入分析，2020-2030-地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 歐洲其他地區
  • 亞太
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第10章：產業格局

  • 併購
  • 協議、合作、合資企業
  • 新產品發布
  • 擴張和其他策略發展

第 11 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 12 章：質子治療系統市場 - 主要公司簡介

  • Varian Medical Systems Inc
  • Hitachi Ltd
  • Sumitomo Heavy Industries Ltd
  • Ion Beam Applications SA
  • Mevion Medical Systems
  • Provision Healthcare LLC
  • ProTom International
  • Optivus Proton Therapy Inc
  • Advanced Oncotherapy plc
  • B dot Medical Inc

第 13 章：附錄

簡介目錄
Product Code: TIPHE100001160

The proton therapy systems market is anticipated to expand from US$ 1,561.07 million in 2024 to US$ 3,274.84 million by 2031, with an estimated CAGR of 11.2% during the period of 2025-2031.

Market Insights and Analyst Perspective:The forecast for the proton therapy systems market can assist stakeholders in this sector in formulating their growth strategies.

A proton therapy system is a sophisticated medical apparatus utilized for delivering highly accurate radiation treatment for tumors. These systems are substantial in size and comprise an accelerator (cyclotron), beam transport system, energy selection system, and rotating gantry irradiation equipment. Due to their efficacy in treating specific cancer types, there is an increasing global demand for proton therapy. Factors such as the rising need for advanced treatments alongside the increasing incidence of cancer, as well as growing governmental support for proton therapy facilities, are driving the growth of the proton therapy systems market. However, the high costs and large footprint of proton therapy systems pose challenges to market expansion. Additionally, the increasing adoption of personalized treatment methods coupled with technological advancements is expected to introduce new trends in the proton therapy systems market in the years ahead.

Growth Drivers:Increasing Demand for Advanced Treatments Amid Rising Cancer Incidence Fuels Market Growth

According to the International Agency for Research on Cancer (IARC), lung, breast, and prostate cancers had the highest incidence rates in 2022, with age-standardized rates of 23.6, 47.1, and 29.4 cases per 100,000 population, respectively. IARC estimates indicate that the total number of cancer cases is projected to rise from 19.98 million in 2022 to 23.71 million by 2030 and 30.97 million by 2045. Various cancer types, including head and neck cancers (nasal, oral, eye, and larynx) and brain cancers, have specific treatment needs, leading to a heightened demand for advanced treatment modalities such as intensity-modulated proton therapy (IMPT). Traditional radiation therapies, like X-ray radiation therapy, also expose healthy tissues surrounding the tumor to radiation, resulting in side effects and potential secondary cancers. In contrast, proton therapy effectively treats complex tumors in the brain and head and neck regions while minimizing damage to adjacent healthy tissues. Therefore, the high prevalence of cancer and the demand for advanced treatment options are propelling the growth of the proton therapy systems market.

Strategic Insights

Restraint:High Costs and Large Footprint of Proton Therapy Systems

A proton therapy system is a sophisticated medical device utilized for precise radiation treatment of tumors. It is a large apparatus that includes an accelerator (cyclotron), beam transport system, energy selection system, and rotating gantry irradiation equipment, resulting in significant space requirements and high equipment costs. According to the University of Pennsylvania (Oncolink), cyclotrons in proton therapy systems can weigh up to 200 tons and have diameters of 6-12 feet. The gantry can weigh around 100 tons and measure 40 feet in diameter. A study published in 2021 in IOPscience indicates that even a compact design (single-room setup) requires an area of 100 sq. m., while multi-room proton therapy systems need 200-400 sq. m. of space.

Moreover, proton therapy systems are highly capital-intensive. For example, a single-room system may cost approximately US$ 30-50 million, while multi-gantry proton systems can start at around US$ 300 million, typically installed only in large hospitals and university systems. Consequently, the substantial capital investment and extensive installation space required are significant factors hindering the growth of the proton therapy systems market.

Report Segmentation and Scope:The analysis of the proton therapy systems market has been conducted by examining the following segments: setup type and application.

By setup type, the market is divided into single room and multi room. The multi room segment held a larger share of the proton therapy systems market in 2022. Furthermore, the single room segment is expected to exhibit a faster CAGR during the forecast period.

In terms of application, the market is categorized into brain and central nervous system cancer, head and neck cancer, prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, and others. The brain and central nervous system cancer segment accounted for the largest share of the proton therapy systems market in 2022 and is projected to register the highest CAGR during the forecast period.

Regional Analysis:Geographically, the scope of the proton therapy systems market report encompasses North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest market share. The increasing acceptance and adoption of advanced medical devices, the high prevalence of cancer, and product innovations by key players contribute to the growth of the proton therapy systems market in North America. According to estimates from the American Cancer Society, the US recorded approximately 1.95 million new cancer cases and around 0.61 million cancer-related deaths in 2023, showing a significant rise from 1.60 million cases and 0.60 million deaths reported in 2020. As per the Particle Therapy Co-Operative Group, by the end of 2023, the US had the highest number of proton therapy systems globally, with 46 treatment facilities.

Proton Therapy Systems Market Report Scope

Industry Developments and Future Opportunities:Several strategic developments by leading players in the proton therapy systems market, as reported in company press releases, are highlighted below:

In January 2024, OncoRay introduced a prototype for a whole-body MRI-guided proton therapy system designed for real-time tracking of moving tumors using magnetic resonance imaging (MRI) during treatment. The MRI enhances tumor visualization, providing better contrast compared to traditional imaging methods, allowing for more accurate delineation of the tumor from surrounding healthy tissue and improved definition of the irradiated volume.

In December 2023, HKSH Medical Group inaugurated a new proton therapy center at the HKSH Eastern Medical Centre in A Kung Ngam, Shau Kei Wan, Hong Kong. This center features an advanced proton therapy system and two state-of-the-art treatment rooms, including two half-rotating proton therapy gantries, the latest beam transport system, and a synchrotron-based accelerator.Competitive Landscape and Key Companies:Prominent companies profiled in the proton therapy systems market report include Varian Medical Systems Inc, Sumitomo Heavy Industries Ltd, Hitachi Ltd, Ion Beam Applications SA, Mevion Medical Systems, Provision Healthcare LLC, ProTom International, Optivus Proton Therapy Inc, Advanced Oncotherapy plc, and B dot Medical Inc. These companies are focused on developing new technologies, enhancing existing products, and expanding their geographic reach to meet the increasing global demand.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Proton Therapy Systems Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Proton Therapy Systems Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Proton Therapy Systems Market - Global Market Analysis

  • 6.1 Proton Therapy Systems - Global Market Overview
  • 6.2 Proton Therapy Systems - Global Market and Forecast to 2030

7. Proton Therapy Systems Market - Revenue Analysis (USD Million) - By Set-up Type, 2020-2030

  • 7.1 Overview
  • 7.2 Single Room
  • 7.3 Multi Room

8. Proton Therapy Systems Market - Revenue Analysis (USD Million) - By Application, 2020-2030

  • 8.1 Overview
  • 8.2 Brain and Central Nervous System Cancer
  • 8.3 Head and Neck Cancer
  • 8.4 Prostate Cancer
  • 8.5 Breast Cancer
  • 8.6 Lung Cancer
  • 8.7 Gastrointestinal Cancer
  • 8.8 Others

9. Proton Therapy Systems Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Proton Therapy Systems Market Overview
    • 9.1.2 North America Proton Therapy Systems Market Revenue and Forecasts to 2030
    • 9.1.3 North America Proton Therapy Systems Market Revenue and Forecasts and Analysis - By Set-up Type
    • 9.1.4 North America Proton Therapy Systems Market Revenue and Forecasts and Analysis - By Application
    • 9.1.5 North America Proton Therapy Systems Market Revenue and Forecasts and Analysis - By Countries
      • 9.1.5.1 United States Proton Therapy Systems Market
        • 9.1.5.1.1 United States Proton Therapy Systems Market, by Set-up Type
        • 9.1.5.1.2 United States Proton Therapy Systems Market, by Application
      • 9.1.5.2 Canada Proton Therapy Systems Market
        • 9.1.5.2.1 Canada Proton Therapy Systems Market, by Set-up Type
        • 9.1.5.2.2 Canada Proton Therapy Systems Market, by Application
      • 9.1.5.3 Mexico Proton Therapy Systems Market
        • 9.1.5.3.1 Mexico Proton Therapy Systems Market, by Set-up Type
        • 9.1.5.3.2 Mexico Proton Therapy Systems Market, by Application
  • 9.2 Europe
    • 9.2.1 Germany
    • 9.2.2 France
    • 9.2.3 Italy
    • 9.2.4 Spain
    • 9.2.5 United Kingdom
    • 9.2.6 Rest of Europe
  • 9.3 Asia-Pacific
    • 9.3.1 Australia
    • 9.3.2 China
    • 9.3.3 India
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 Rest of Asia-Pacific
  • 9.4 Middle East and Africa
    • 9.4.1 South Africa
    • 9.4.2 Saudi Arabia
    • 9.4.3 U.A.E
    • 9.4.4 Rest of Middle East and Africa
  • 9.5 South and Central America
    • 9.5.1 Brazil
    • 9.5.2 Argentina
    • 9.5.3 Rest of South and Central America

10. Industry Landscape

  • 10.1 Mergers and Acquisitions
  • 10.2 Agreements, Collaborations, Joint Ventures
  • 10.3 New Product Launches
  • 10.4 Expansions and Other Strategic Developments

11. Competitive Landscape

  • 11.1 Heat Map Analysis by Key Players
  • 11.2 Company Positioning and Concentration

12. Proton Therapy Systems Market - Key Company Profiles

  • 12.1 Varian Medical Systems Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Hitachi Ltd
  • 12.3 Sumitomo Heavy Industries Ltd
  • 12.4 Ion Beam Applications SA
  • 12.5 Mevion Medical Systems
  • 12.6 Provision Healthcare LLC
  • 12.7 ProTom International
  • 12.8 Optivus Proton Therapy Inc
  • 12.9 Advanced Oncotherapy plc
  • 12.10 B dot Medical Inc

13. Appendix

  • 13.1 Glossary
  • 13.2 About The Insight Partners
  • 13.3 Market Intelligence Cloud